The most recent 'past' review, or the one we know about, recommended changes to pharmacy location rules, the virtual abolition of price competition, the introduction of Pharmac-style tenders for the PBS, a profound shift in dispensing remuneration, and a review of arrangements for wholesaler distribution.
The worrying reference to 'past findings and recommendations of reviews'
August 9, 2023 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
The symptoms have been identified, but the widely held belief about the cause is a miss
September 30, 2025 - - Latest News -
UK companies are granted more time to decide on pricing agreement
September 29, 2025 - - Latest News -
Anatara strengthens board with the appointment of Dirk van Dissel
September 29, 2025 - - Australian Biotech -
CLINUVEL advances next-generation peptide drug formulations
September 29, 2025 - -
Alterity Therapeutics targets major market with ATH434 in Multiple System Atrophy
September 29, 2025 - - Australian Biotech -
Lower than expected uptake of new therapies impacts PBS spend
September 29, 2025 - - Latest News -
Chimeric reports encouraging early data from CHM CDH17 trial
September 29, 2025 - - Australian Biotech